These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26900658)

  • 1. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
    Kucwaj-Brysz K; Warszycki D; Podlewska S; Witek J; Witek K; González Izquierdo A; Satała G; Loza MI; Lubelska A; Latacz G; Bojarski AJ; Castro M; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2016 Apr; 112():258-269. PubMed ID: 26900658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
    Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between stereochemical and both, pharmacological and ADME-Tox, properties of the potent hydantoin 5-HT
    Kucwaj-Brysz K; Latacz G; Podlewska S; Żesławska E; Handzlik J; Lubelska A; Satała G; Nitek W; Handzlik J
    Bioorg Chem; 2021 Jan; 106():104466. PubMed ID: 33246603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
    Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Kucwaj-Brysz K; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Bioorg Med Chem Lett; 2018 Mar; 28(5):878-883. PubMed ID: 29439902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In the search for a lead structure among series of potent and selective hydantoin 5-HT
    Latacz G; Lubelska A; Jastrzębska-Więsek M; Partyka A; Sobiło A; Olejarz A; Kucwaj-Brysz K; Satała G; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Chem Biol Drug Des; 2017 Dec; 90(6):1295-1306. PubMed ID: 28886235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
    Handzlik J; Bojarski AJ; Satała G; Kubacka M; Sadek B; Ashoor A; Siwek A; Więcek M; Kucwaj K; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2014 May; 78():324-39. PubMed ID: 24691057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of aryl-topology in balancing between selective and dual 5-HT
    Kucwaj-Brysz K; Kurczab R; Żesławska E; Lubelska A; Marć MA; Latacz G; Satała G; Nitek W; Kieć-Kononowicz K; Handzlik J
    Medchemcomm; 2018 Jun; 9(6):1033-1044. PubMed ID: 30108992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
    Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
    Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel N-acyl-carbazole derivatives as 5-HT7R antagonists.
    Kim Y; Yeom M; Tae J; Rhim H; Choo H
    Eur J Med Chem; 2016 Mar; 110():302-10. PubMed ID: 26852005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEW SPIROHYDANTOIN DERIVATIVES - SYNTHESIS, PHARMACOLOGICAL EVALUATION, AND MOLECULAR MODELING STUDY.
    Czopek A; Zagorska A; Kolaczkowski M; Bucki A; Gryzlo B; Rychtyk J; Pawlowsk M; Siwek A; Satala G; Bojarski A; Kubacka M; Filipek B
    Acta Pol Pharm; 2016 Nov; 73(6):1545-1554. PubMed ID: 29634109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
    Zhuang ZP; Kung MP; Mu M; Kung HF
    J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards new 5-HT7 antagonists among arylsulfonamide derivatives of (aryloxy)ethyl-alkyl amines: Multiobjective based design, synthesis, and antidepressant and anxiolytic properties.
    Canale V; Kurczab R; Partyka A; Satała G; Lenda T; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Zajdel P
    Eur J Med Chem; 2016 Jan; 108():334-346. PubMed ID: 26698537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.
    Kim Y; Park H; Lee J; Tae J; Kim HJ; Min SJ; Rhim H; Choo H
    Eur J Med Chem; 2016 Nov; 123():180-190. PubMed ID: 27475109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT
    Jankowska A; Satała G; Kołaczkowski M; Bucki A; Głuch-Lutwin M; Świerczek A; Pociecha K; Partyka A; Jastrzębska-Więsek M; Lubelska A; Latacz G; Gawalska A; Bojarski AJ; Wyska E; Chłoń-Rzepa G
    Eur J Med Chem; 2020 Sep; 201():112437. PubMed ID: 32673902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and computer-aided analysis of the role of linker for novel ligands of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Satała G; Kieć-Kononowicz K; Handzlik J
    Bioorg Chem; 2019 Mar; 84():319-325. PubMed ID: 30530073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
    Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P
    Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multiobjective based design, synthesis and evaluation of the arylsulfonamide/amide derivatives of aryloxyethyl- and arylthioethyl- piperidines and pyrrolidines as a novel class of potent 5-HT₇ receptor antagonists.
    Zajdel P; Kurczab R; Grychowska K; Satała G; Pawłowski M; Bojarski AJ
    Eur J Med Chem; 2012 Oct; 56():348-60. PubMed ID: 22926225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.